Frank Ling
Paris, 75010, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemia.
Journal: Science translational medicine
Published: July 08, 2026
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms.
Journal: Nature communications
Published: February 23, 2024
Targeting a lineage-specific PI3Kɣ-Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader molecule.
Journal: Nature cancer
Published: October 24, 2023
A multiparametric niche-like drug screening platform in acute myeloid leukemia.
Journal: Blood cancer journal
Published: November 30, 2021
Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia.
Journal: Leukemia
Published: October 12, 2021
Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitor.
Journal: Science translational medicine
Published: December 12, 2020
Targeting serine hydroxymethyltransferases 1 and 2 for T-cell acute lymphoblastic leukemia therapy.
Journal: Leukemia
Published: February 02, 2020
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting Therapies.
Journal: Cancer discovery
Published: August 18, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026